A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer

NCT03336216 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Pancreatic Cancer

Interventions

BIOLOGICAL: Cabiralizumab
DRUG: Nab-paclitaxel
DRUG: Onivyde
BIOLOGICAL: Nivolumab
DRUG: Fluorouracil
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Leucovorin
DRUG: Irinotecan Hydrochloride

Sponsor

Bristol-Myers Squibb